Ethacrynic acid inhibits the growth and proliferation of prostate cancer cells by targeting GSTP1 and regulating the PI3K-AKT signaling pathway
The International Journal of Biochemistry & Cell Biology · 2025
DOI: 10.1016/j.biocel.2025.106740 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2025. Verfasst von Bin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, People's Hospital Affiliated of Quanzhou Medical College, Quanzhou 362000, China; The Second Clinical Medical College of Fujia…. Hauptthemen laut MEDLINE: Glutathione S-Transferase pi, Proto-Oncogene Proteins c-akt, Prostatic Neoplasms, Cell Proliferation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Quanzhou City Science and Technology Program, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
BACKGROUND: As a diuretic, ethacrynic acid (EA) has been shown to play a suppressive role in cancers, including prostate cancer (PC). However, its molecular regulatory mechanism is still unclear. Therefore, our study is centered on investigating the effect of EA on PC development and its mechanism. METHODS: To verify the binding relationship between EA and GSTP1, molecular docking and cellular thermal shift assay (CETSA) were conducted. To examine how EA affects PC cell proliferation, cell cycle, and apoptosis, cell function assays were performed. qRT-PCR was used to detect GSTP1 mRNA expression. The expression of GSTP1 protein and PI3K-AKT signaling pathway-related proteins in cells was detected by western blot (WB). To verify how EA and GSTP1 influence cell growth in PC, in vivo experiments were conducted. RESULTS: The binding relationship between GSTP1 and EA was confirmed by molecular docking and CETSA results. Cell experiments showed that EA could hinder PI3K/AKT pathway and PC cell proliferation, arrest the cell cycle in G0/G1 phase, and facilitate apoptosis by binding to GSTP1. In vivo experiments in nude mice verified that the interaction between EA and GSTP1 reduced PI3K and AKT phosphorylation and inhibited the growth of PC cells. CONCLUSION: EA inhibits PC progression by binding to GSTP1 to downregulate the activity of PI3K/AKT pathway, and this result suggests the potential of EA to be an anticancer agent for PC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, People's Hospital Affiliated of Quanzhou Medical College, Quanzhou 362000, China; The Second Clinical Medical College of Fujian Medical University, Quanzhou 362000, China.
- The Second Clinical Medical College of Fujian Medical University, Quanzhou 362000, China.
- The Second Clinical Medical College of Fujian Medical University, Quanzhou 362000, China; Department of Urology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China. Electronic address: c…
Förderung
- Quanzhou City Science and Technology Program
- Natural Science Foundation of Fujian Province
Zitieren
APA
Zhao, B., Zhang, B., Chenzhang, M., Jiang, K., Wang, D., & Chen, J. (2025). Ethacrynic acid inhibits the growth and proliferation of prostate cancer cells by targeting GSTP1 and regulating the PI3K-AKT signaling pathway. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2025.106740
Vancouver
Zhao B, Zhang B, Chenzhang M, Jiang K, Wang D, Chen J. Ethacrynic acid inhibits the growth and proliferation of prostate cancer cells by targeting GSTP1 and regulating the PI3K-AKT signaling pathway. The International Journal of Biochemistry & Cell Biology. 2025. doi:10.1016/j.biocel.2025.106740
BibTeX
@article{Zhao2025,
author = {Zhao, Bin and Zhang, Bingfeng and Chenzhang, Minhao and Jiang, Kangxian and Wang, Dianyu and Chen, Junyi},
title = {Ethacrynic acid inhibits the growth and proliferation of prostate cancer cells by targeting GSTP1 and regulating the PI3K-AKT signaling pathway},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2025},
doi = {10.1016/j.biocel.2025.106740}
}
EUVIMED